Patent
Peptide reagent for the detection of human cytomegalovirus (CMV)
العنوان: | Peptide reagent for the detection of human cytomegalovirus (CMV) |
---|---|
Patent Number: | 6,936,251 |
تاريخ النشر: | August 30, 2005 |
Appl. No: | 10/288220 |
Application Filed: | November 05, 2002 |
مستخلص: | The invention relates to a peptide reagent comprising peptides immunochemically reactive with antibodies to the human cytomegalovirus (CMV). New antibodies directed to said peptides or fragments thereof are also part of the invention. Also cell lines capable of producing monoclonal antibodies are part of the invention. The invention also relates to a method for the detection of CMV or antibodies directed against CMV in a test fluid and a test kit to be used when applying the said detection methods. Detection of CMV in a test fluid or tissue specimen using antibodies, monoclonal and polyclonal, directed to said peptide, which have the characteristics of detecting both native and denatured DMV proteins are also part of said invention. |
Inventors: | Middeldorp, Jaap Michiel (Oss, NL); Van De Crommert, Johannes Martinus Gerardus (Veghel, NL) |
Assignees: | bioMerieux, B.V. (Boxtal, NL) |
Claim: | 1. An isolated peptide reagent, comprising a first peptide comprising the amino acid sequence of SEQ ID NO:1, a second peptide comprising the amino acid sequence of SEQ ID NO:7 and a third peptide comprising the amino acid sequence of SEQ ID NO:10. |
Claim: | 2. A peptide reagent, consisting of a first peptide consisting of the amino acid sequence of SEQ ID NO:1, a second, separate peptide consisting of the amino acid sequence of SEQ ID NO:7, and a third, separate peptide consisting of the amino acid sequence of SEQ ID NO:10. |
Claim: | 3. A method for the detection of antibodies to CMV in a sample, comprising contacting the peptide reagent of claim 1 with the sample under conditions whereby an antigen/antibody complex can form and detecting formation of an antigen/antibody complex, thereby detecting antibodies to CMV in the sample. |
Claim: | 4. A method for the detection of antibodies to CMV in a sample, comprising contacting the peptide reagent of claim 2 with the sample under conditions whereby an antigen/antibody complex can form and detecting formation of an antigen/antibody complex, thereby detecting antibodies to CMV in the sample. |
Claim: | 5. A test kit comprising the peptide reagent of claim 1 . |
Claim: | 6. A test kit comprising the peptide reagent of claim 2 . |
Current U.S. Class: | 4241/861 |
Patent References Cited: | 5744298 April 1998 Stuber et al. 5859185 January 1999 Stuber et al. 6120989 September 2000 Vornhagen et al. 3619902 March 1988 4128684 April 1993 4426453 November 1995 236145 September 1987 0 248 909 December 1987 0 330 051 August 1989 WO 92/00323 January 1992 |
Other References: | Ayata et al., Journal of General Virology, vol. 43, pp. 380-392 (1994). cited by examiner NCBI printout of Accession P06473, Glycoprotein B precursor (Jan 1988). cited by examiner NCBI printout of Accession P13200, 28 KD Structural Phosphoprotein (Jan 1990). cited by examiner Sundqvist et al., Journal of Clinical Microbiology, vol. 30, No. 10, pp. 2735-2739 (Oct 1992). cited by examiner NCBI printout of Accession P08318, Large Structural Phosphoprotein (PP150) . . . (Aug 1988). cited by examiner Ripalti et al., Journal of Clinical Microbiology, vol. 32, No. 2, pp. 358-363 (Feb 1994). cited by examiner Landini et al., Journal of Clinical Microbiology, vol. 29, No. 9, pp. 1863-1872 (Sept 1991). cited by examiner Giugni et al. 1992. Journal of Virology 73:2367-2374. cited by other Marshall et al. 1994. Journal of Medical Virology 43:77-83. cited by other Meyer et al. Sep. 1989. Database PIR 68, Accession No. WMBE28. cited by other Shiu et al. Feb. 1995. Database PIR 68, Accession No. S40226. cited by other Ayata et al. “Different Antibody Response to a Neutralizing Epitope of Human Cytomegalovirus Glycoprotein B Among Seropositive Individuals” Journal of Medical Virology 43:386-392 (1994). cited by other Greijer et al. “Molecular Fine-Specificity Analysis of Antibody Responses to Human Cytomegalovirus and Design of Novel Synthetic-Peptide-Based Serodiagnostic Assays” Journal of Clinical Microbiology 37(1):179-188 (1999). cited by other International Search Report corresponding to PCT/EP 97/03717 mailed on Nov. 14, 1997. cited by other Van Zanten et al. “Comparative Immunoblot Analysis with Ten Different, Partially Overlapping Recombinant Fusion Proteins Derived From Five Different Cytomegalovirus Proteins” Microbiologica 18:223-228 (1995). cited by other |
Assistant Examiner: | Lucas, Zachariah |
Primary Examiner: | Housel, James |
Attorney, Agent or Firm: | Myers, Bigel, Sibley & Sajovec, P.A. |
رقم الانضمام: | edspgr.06936251 |
قاعدة البيانات: | USPTO Patent Grants |
كن أول من يترك تعليقا!